On Tuesday, Blueprint Medicines Corp (BPMC) stock saw a decline, ending the day at $90 which represents a decrease of $-2.50 or -2.70% from the prior close of $92.5. The stock opened at $91.63 and ...

Blueprint Medicines' AYVAKIT continues to gain traction among key stakeholders. See more on BPMC stock and the factors ...

On Friday, Blueprint Medicines Corp (BPMC) stock saw a modest uptick, ending the day at $92.55 which represents a slight increase of $3.49 or 3.92% from the prior close of $89.06. The stock opened at ...

Buy and Sell Signals for Blueprint Medicines Corporation BPMC that help investors manage their investment in BPMC ...

For the first time, patients with indolent SM have a medicine that treats the primary disease driver and is proven to provide broad and durable symptom relief ---- Approval based ...

Below is Validea's guru fundamental report for BLUEPRINT MEDICINES CORP (BPMC). Of the 22 guru strategies we follow, BPMC rates highest using our Quantitative Momentum Investor model based on the ...

Blueprint Medicines Corporation (Nasdaq: BPMC) today reported financial results, provided a business update for the second quarter ended June 30, 2024, and provided updated financial guidance.

Driehaus Capital Management LLC boosted its holdings in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 101.0% in the 2nd quarter, according to the company in its most recent 13F filing ...

C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday Why bluebird bio Shares Are Trading Higher? Here ...

After losing some value lately, a hammer chart pattern has been formed for Blueprint Medicines (BPMC), indicating that the stock has found support. This, combined with an upward trend in earnings ...

View Blueprint Medicines Corporation (BPMC) current and estimated P/E ratio data provided by Seeking Alpha.